Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 07, 2022 16:01 ET | Source: FibroGen, Inc.

FibroGen Reports Third Quarter 2022 Financial Results

Continued advancement of pamrevlumab clinical trials – topline data from five pivotal Phase 3 trials beginning in 1H 2023 through mid-2024Completed enrollment of MATTERHORN Phase 3 study of roxadustat...
November 07, 2022 16:00 ET | Source: FibroGen, Inc.

FibroGen Announces $50 Million Royalty Monetization Financing with NovaQuest Capital Management

Strengthens balance sheet with strategic non-dilutive capital to support strategic prioritiesSupported by global launches of EVRENZO™ in the territories partnered with Astellas Pharma Inc.FibroGen...